ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

In Brief: Lawyers Halt Reference Chemical Distribution To Grantees, Threaten To Stop Viruses, Animals

September 2, 1977

NCI to Fund 122 More Grants in FY04

March 28, 2003

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.

July 28, 2000